Different Stages of Cardiovascular–Kidney–Metabolic Syndrome Associated With the Risk of All‐Cause and Cause‐Specific Mortality: Insights From Two Prospective Cohort Studies
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/1409909 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 02.08.2026. Verfasst von Xiangyu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Zhengzhou University, Zhengzhou Henan, 450001, China, zzu.edu.cn. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Stage 3 in cardiovascular–kidney–metabolic (CKM) syndrome, defined as subclinical cardiovascular disease (CVD), diagnosis often relies on risk equivalents (very high‐risk CKD or high 10‐year CVD risk) due to the limited accessibility of diagnostic tools. A critical unanswered question is whether these two risk‐equivalent subgroups exhibit comparable mortality risks. This study compares mortality risks between these subgroups.
Methods
The study included 344,515 participants from the UK Biobank and 24,545 participants from the National Health and Nutrition Examination Survey (NHANES). Participants were stratified according to AHA diagnostic criteria into Stage 0, 1, 2, 3, and 4. Stage 3 was further subclassified as 3a (10‐year high risk of CVD) and 3b (very high‐risk CKD). Cox proportional hazards regression models were applied to assess the risks of all‐cause, cardiovascular, renal, and cancer mortality across different stages.
Results
In the UK Biobank, compared with Stage 0, Stage 3b was associated with the second‐highest multivariable‐adjusted hazard ratios (HRs) for all‐cause mortality (4.95; 95% CI: 4.41–5.55), cardiovascular mortality (18.75; 95% CI: 14.70–23.91), renal mortality (59.73; 95% CI: 21.53–165.68), and cancer mortality (2.88; 95% CI: 2.33–3.56), second only to Stage 4b. These risks were significantly higher than those observed in Stage 3a and even exceeded those in Stage 4a. The analysis of the NHANES cohort also validated the results for all‐cause mortality and cardiovascular mortality risks described above.
Conclusion
The patients in Stage 3b with very high‐risk CKD, even in the absence of clinical CVD, face a very high risk of mortality and should be given significant attention and early intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Public Health, Zhengzhou University, Zhengzhou Henan, 450001, China, zzu.edu.cn.
- Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China, ccmu.edu.cn.
ORCID-Profile: Xiangyu Wang, Mengge Yang, Qunwei Ma, Xiaona Chang, Guang Wang, Jia Liu, Jian Wu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Yang, M., Ma, Q., Chang, X., Wang, G., Liu, J., & Wu, J. (2026). Different Stages of Cardiovascular–Kidney–Metabolic Syndrome Associated With the Risk of All‐Cause and Cause‐Specific Mortality: Insights From Two Prospective Cohort Studies. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/1409909
Vancouver
Wang X, Yang M, Ma Q, Chang X, Wang G, Liu J, et al. Different Stages of Cardiovascular–Kidney–Metabolic Syndrome Associated With the Risk of All‐Cause and Cause‐Specific Mortality: Insights From Two Prospective Cohort Studies. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/1409909
BibTeX
@article{Wang2026,
author = {Wang, Xiangyu and Yang, Mengge and Ma, Qunwei and Chang, Xiaona and Wang, Guang and Liu, Jia and Wu, Jian},
title = {Different Stages of Cardiovascular–Kidney–Metabolic Syndrome Associated With the Risk of All‐Cause and Cause‐Specific Mortality: Insights From Two Prospective Cohort Studies},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/1409909}
}
EUVIMED